| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(12)62189-8 |
| P698 | PubMed publication ID | 23498095 |
| P50 | author | Nicole Lurie | Q7030108 |
| Grace M Lee | Q105289067 | ||
| Claudia Vellozzi | Q105724602 | ||
| William Bleser | Q55201971 | ||
| Richard Forshee | Q55201974 | ||
| Sharon K Greene | Q56806940 | ||
| Daniel A Salmon | Q57294972 | ||
| P2093 | author name string | Paul Gargiullo | |
| Bruce Gellin | |||
| W Katherine Yih | |||
| Michael Proschan | |||
| Francesca Cunningham | |||
| Dale R Burwen | |||
| Patrick Garman | |||
| H1N1 GBS Meta-Analysis Working Group | |||
| P2860 | cites work | No Association Between Immunization and Guillain-Barré Syndrome in the United Kingdom, 1992 to 2000 | Q57388524 |
| Influenza vaccine, Guillain–Barré syndrome, and chasing zero | Q57540054 | ||
| Guillain-Barré Syndrome After Influenza Vaccination in Adults | Q57661024 | ||
| Reassessment of the Association between Guillain-Barré Syndrome and Receipt of Swine Influenza Vaccine in 1976–1977: Results of a Two-State Study | Q64128491 | ||
| Guillain-Barré Syndrome and the 1978–1979 Influenza Vaccine | Q70771999 | ||
| Guillain-Barré syndrome and its relationship to swine influenza vaccination in Michigan, 1976-1977 | Q71379876 | ||
| Evaluation of Guillain-Barré Syndrome Among Recipients of Influenza Vaccine in 2000 and 2001 | Q85022814 | ||
| Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis | Q22241939 | ||
| Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data | Q22251433 | ||
| The Vaccine Safety Datalink: a model for monitoring immunization safety | Q27010367 | ||
| Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities | Q28741469 | ||
| Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. | Q30373486 | ||
| Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. | Q30383245 | ||
| Estimating the Burden of 2009 Pandemic Influenza A (H1N1) in the United States (April 2009-April 2010) | Q30400038 | ||
| Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe | Q30404728 | ||
| H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project | Q30404999 | ||
| Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010. | Q30416712 | ||
| Effects of Vaccine Program against Pandemic Influenza A(H1N1) Virus, United States, 2009–2010 | Q30429825 | ||
| Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. | Q33280997 | ||
| Tutorial in biostatistics: the self-controlled case series method | Q33368891 | ||
| Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program | Q33876202 | ||
| Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977 | Q34215590 | ||
| Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination | Q34278694 | ||
| Influenza vaccination and mortality: differentiating vaccine effects from bias | Q37310234 | ||
| Guillain-Barre Syndrome During the 2009-2010 H1N1 Influenza Vaccination Campaign: Population-based Surveillance Among 45 Million Americans | Q37463235 | ||
| Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. | Q38009803 | ||
| Chart-Confirmed Guillain-Barre Syndrome After 2009 H1N1 Influenza Vaccination Among the Medicare Population, 2009-2010 | Q38104881 | ||
| Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. | Q38438386 | ||
| Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988. | Q41890248 | ||
| Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination | Q43605309 | ||
| An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines | Q45171417 | ||
| Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organization | Q46214911 | ||
| A note on graphical presentation of estimated odds ratios from several clinical trials | Q52553734 | ||
| Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team | Q53148418 | ||
| The Risk of Guillain–Barré Syndrome Associated with Influenza A (H1N1) 2009 Monovalent Vaccine and 2009–2010 Seasonal Influenza Vaccines: Results from Self‐Controlled Analyses | Q53645955 | ||
| Surveillance for Guillain–Barré Syndrome After Influenza Vaccination Among the Medicare Population, 2009–2010 | Q56545391 | ||
| P433 | issue | 9876 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United States | Q30 |
| Guillain–Barré syndrome | Q205214 | ||
| meta-analysis | Q815382 | ||
| influenza A virus subtype H1N1 | Q161393 | ||
| P304 | page(s) | 1461-1468 | |
| P577 | publication date | 2013-03-13 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis | |
| P478 | volume | 381 |
| Q41844412 | A case of myositis of the deltoid muscle of the upper arm developing 1 week after influenza vaccination: case report |
| Q45162452 | Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season |
| Q60936089 | Active surveillance for safety monitoring of seasonal influenza vaccines in Italy, 2015/2016 season |
| Q57096176 | Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009-2010 season in the active component U.S. military and civilians aged 17-44years reported to the Vaccine Adverse Event Reporting S |
| Q30352329 | An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. |
| Q28300023 | Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study |
| Q30380365 | Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. |
| Q33770375 | Clinical Features of Post-Vaccination Guillain-Barré Syndrome (GBS) in Korea. |
| Q33165769 | Deaths following vaccination: What does the evidence show? |
| Q43700573 | Did the influenza A (H1N1) 2009 monovalent inactivated vaccines increase the risk for Guillain-Barré syndrome? |
| Q38587703 | Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach. |
| Q98771438 | Do Vaccines Have a Role as a Cause of Autoimmune Neurological Syndromes? |
| Q90429655 | Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barré Syndrome and Narcolepsy |
| Q38153635 | Emerging infections of the central nervous system |
| Q26828904 | Ethics of mandatory vaccination for healthcare workers |
| Q30234430 | Frequently asked questions on seven rare adverse events following immunization |
| Q34271547 | Guillain-Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States |
| Q30351998 | Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011. |
| Q28273931 | Guillain-Barré syndrome |
| Q30357675 | Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe |
| Q30374886 | Guillain-Barré syndrome and influenza vaccines: A meta-analysis. |
| Q92978114 | Guillain-Barré syndrome and influenza vaccines: current evidence |
| Q30388367 | Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide [...] |
| Q22251013 | Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis |
| Q38656976 | Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France |
| Q34700616 | In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases |
| Q42242519 | Increased emergency room visits or hospital admissions in females after 12-month MMR vaccination, but no difference after vaccinations given at a younger age. |
| Q38125242 | Infectious and noninfectious triggers in Guillain–Barré syndrome |
| Q58051969 | Influenza Vaccine and Autoimmune Diseases |
| Q30354181 | Influenza vaccination in India: position paper of Indian Academy of Pediatrics, 2013. |
| Q42265180 | Influenza vaccine and Guillain-Barré syndrome: making informed decisions |
| Q49345779 | Influenza vaccines: Evaluation of the safety profile |
| Q30431960 | International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines |
| Q33416609 | Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events |
| Q38936903 | No increased risk of Guillain-Barré syndrome after human papilloma virus vaccine: A self-controlled case-series study in England |
| Q37118671 | Ontology-based Vaccine and Drug Adverse Event Representation and Theory-guided Systematic Causal Network Analysis toward Integrative Pharmacovigilance Research |
| Q41156699 | Overall conceptual framework for studying the genetics of autoimmune diseases following vaccination: a regulatory perspective |
| Q30359657 | Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome. |
| Q30372280 | Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea. |
| Q30377161 | Paresthesia and sensory disturbances associated with 2009 pandemic vaccine receipt: Clinical features and risk factors. |
| Q38194216 | Perspectives on the future of postmarket vaccine safety surveillance and evaluation |
| Q53206970 | Quantitative Bias Analysis in Regulatory Settings. |
| Q41273106 | Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage |
| Q30370076 | Responding to vaccine safety signals during pandemic influenza: a modeling study. |
| Q41995480 | Risk of Guillain-Barré Syndrome following quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink. |
| Q30374961 | Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study. |
| Q30362413 | Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany |
| Q42181872 | Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an update |
| Q93016369 | Should rare immunologic, neurologic, and other adverse events be indications to withhold vaccination? |
| Q90082688 | Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries |
| Q92252833 | Surveillance for Guillain-Barré syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season |
| Q30203549 | The narcolepsy-pandemic influenza story: can the truth ever be unraveled? |
| Q26773027 | The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper |
| Q91826121 | The state of vaccine safety science: systematic reviews of the evidence |
| Q36142449 | Vaccine Safety Resources for Nurses |
| Q59395283 | Vaccine-preventable diseases, vaccines and Guillain-Barre’ syndrome |
Search more.